Supplementary Figure S2 from RIT1<sup>M90I</sup> Is a Driver of Lung Adenocarcinoma Tumorigenesis and Resistance to Targeted Therapy
<p>Supplementary Figure S2: Ex vivo RIT1 cell lines have Trp53 genetic knockout and therapeutic vulnerabilities include MAPK/PI3K inhibitors and statins.</p>
Authors
- Jeff Lau (ORCID: https://orcid.org/0009-0006-6526-2222)
- Wennie Chen
- Klára Tótpál (ORCID: https://orcid.org/0000-0001-6629-6623)
- Danilo Maddalo (ORCID: https://orcid.org/0000-0002-3228-1703)
- Luca Gerosa (ORCID: https://orcid.org/0000-0001-6805-9410)
- Monika Miś
- Nicole M. Sodir (ORCID: https://orcid.org/0000-0002-9919-2190)
- Jennifer A. Lacap
- Pablo Saenz-Lopez Larrocha
- Anthony Lima (ORCID: https://orcid.org/0000-0002-6847-2085)
- Kai Barck (ORCID: https://orcid.org/0000-0003-1052-5719)
- Mirunalini Ravichandran (ORCID: https://orcid.org/0000-0002-1991-5695)
- Charles Havnar (ORCID: https://orcid.org/0000-0003-1505-0505)
- Eva Lin (ORCID: https://orcid.org/0009-0001-6099-3847)
- Ashley V. DiMarco (ORCID: https://orcid.org/0000-0001-7352-9093)
- Mark Merchant (ORCID: https://orcid.org/0000-0003-0690-8581)
- Oded Foreman (ORCID: https://orcid.org/0000-0001-8197-3186)
- Thomas Hunsaker (ORCID: https://orcid.org/0000-0001-7665-747X)
- Julie Weng
- Yang Xiao
Publication Details
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1158/0008-5472.30029573
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00